UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2016-03, Vol.387 (10023), p.1066-1074

2016

Volltextzugriff (PDF)

Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

European journal of cancer (1990), 2023-06, Vol.186, p.52-61

2023

Volltextzugriff (PDF)

Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practice

European journal of cancer (1990), 2014-09, Vol.50 (13), p.2303-2308

2014

Volltextzugriff (PDF)

Disease-free survival as an end-point in the treatment of solid tumours – Perspectives from clinical trials and clinical practice

European journal of cancer (1990), 2014-09, Vol.50 (13), p.2298-2302

2014

Volltextzugriff (PDF)

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer

Gynecologic oncology, 2014-11, Vol.135 (2), p.184-189

2014

Volltextzugriff (PDF)

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

Gynecologic oncology, 2010-02, Vol.116 (2), p.163-167

2010

Volltextzugriff (PDF)

Targeted agents: How to select the winners in preclinical and early clinical studies?

European journal of cancer (1990), 2012-01, Vol.48 (2), p.170-178

2012

Volltextzugriff (PDF)

Individual patient data analysis to assess modifications to the RECIST criteria

European journal of cancer (1990), 2009-01, Vol.45 (2), p.248-260

2009

Volltextzugriff (PDF)

Clinical benefit in oncology trials: Is this a patient-centred or tumour-centred end-point?

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2249-2252

2009

Volltextzugriff (PDF)

Connecting communities to tackle cancer from many sides

Cell, 2021-04, Vol.184 (8), p.1949-1952

2021

Volltextzugriff (PDF)

Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)

European journal of cancer (1990), 2008-01, Vol.44 (1), p.19-24

2008

Volltextzugriff (PDF)

Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG)

European journal of cancer (1990), 2010-05, Vol.46 (8), p.1365-1373

2010

Volltextzugriff (PDF)

Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer

Gynecologic oncology, 2013-11, Vol.131 (2), p.315-320

2013

Volltextzugriff (PDF)

Design and conduct of early clinical studies of two or more targeted anticancer therapies: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1808-1814

2013

Volltextzugriff (PDF)

Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17

European journal of cancer (1990), 2016-05, Vol.58, p.97-103

2016

Volltextzugriff (PDF)

Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)

European journal of cancer (1990), 2008-01, Vol.44 (1), p.25-29

2008

Volltextzugriff (PDF)

The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report

European journal of cancer (1990), 2020-05, Vol.131, p.76-88

2020

Volltextzugriff (PDF)

Cancer clinical trial outcomes: Any progress in tumour-size assessment?

European journal of cancer (1990), 2009-01, Vol.45 (2), p.225-227

2009

Volltextzugriff (PDF)

Individual patient data analysis to assess modifications to the RECIST criteria: Response Assessment in Solid Tumours (RECIST): Version 1.1 and supporting papers

European journal of cancer (1990), 2009, Vol.45 (2), p.248-260

2009

Volltextzugriff (PDF)

Endpoints and other considerations in phase I studies of targeted anticancer therapy : Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT). Commentary

European journal of cancer (1990), 2008, Vol.44 (1)

2008

Volltextzugriff (PDF)

Design and conduct of phase II studies of targeted anticancer therapy : Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT). Commentary

European journal of cancer (1990), 2008, Vol.44 (1)

2008

Volltextzugriff (PDF)

A phase I/II study of paclitaxel (Taxol ®) and concurrent radiotherapy in advanced nonsmall cell lung cancer

International journal of radiation oncology, biology, physics, 1997-12, Vol.39 (5), p.1107-1111

1997

Volltextzugriff (PDF)

Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer

Cancer treatment reviews, 1993-10, Vol.19, p.79-86

1993

Volltextzugriff (PDF)

A80 Design of Phase II clinical trials incorporating response and early progression

Controlled clinical trials, 1996-04, Vol.17 (2), p.S85-S85

1996

Volltextzugriff (PDF)

P28 Response criteria in solid tumours: UNI-dimensional vs BI-dimensional measurements

Controlled clinical trials, 1995-06, Vol.16 (3), p.88S-88S

1995

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(23)
Humans
(20)
Oncology
(19)
Hematology, Oncology And Palliative Medicine
(16)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Pharmacology. Drug Treatments
(10)
Female
(9)
Treatment Outcome
(9)
Tumors
(9)
Aged
(8)
Middle Aged
(8)
Antineoplastic Agents - Therapeutic Use
(6)
Disease-Free Survival
(6)
Neoplasms - Drug Therapy
(6)
Obstetrics & Gynecology
(6)
Adult
(5)
Clinical Trials
(5)
Obstetrics And Gynecology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial

Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practice

Disease-free survival as an end-point in the treatment of solid tumours – Perspectives from clinical trials and clinical practice

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

Targeted agents: How to select the winners in preclinical and early clinical studies?

Individual patient data analysis to assess modifications to the RECIST criteria

Clinical benefit in oncology trials: Is this a patient-centred or tumour-centred end-point?

Connecting communities to tackle cancer from many sides

Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)

Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG)

Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer

Design and conduct of early clinical studies of two or more targeted anticancer therapies: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies

Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17

Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)

The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report

Cancer clinical trial outcomes: Any progress in tumour-size assessment?

Individual patient data analysis to assess modifications to the RECIST criteria: Response Assessment in Solid Tumours (RECIST): Version 1.1 and supporting papers

Endpoints and other considerations in phase I studies of targeted anticancer therapy : Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT). Commentary

Design and conduct of phase II studies of targeted anticancer therapy : Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT). Commentary

A phase I/II study of paclitaxel (Taxol ®) and concurrent radiotherapy in advanced nonsmall cell lung cancer

Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer

A80 Design of Phase II clinical trials incorporating response and early progression

P28 Response criteria in solid tumours: UNI-dimensional vs BI-dimensional measurements

Aktive Filter

Suchergebnisse filtern